CD117: A novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies

Cancer Cytopathology

Volumn 122, Issue 8, 2014, Pages 596-603

  Pusztaszeri, Marc P ^a   Sadow, Peter M ^b,c   Faquin, William C ^b,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

C KIT; CD117; Cytopathology; Fine needle aspiration; Immunocytochemistry; Immunohistochemistry; Papillary carcinoma; Thyroid

Indexed keywords

C-KIT; CD117; CYTOPATHOLOGY; FINE-NEEDLE ASPIRATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; THYROID;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 84906852482     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21437     Document Type: Article

References (25)

1. Rosai J, Carangiu ML, DeLellis. Atlas of Tumor Pathology: Tumors of the Thyroid Gland. Washington, DC: Armed Forces Institute of Pathology; 1992.
2. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and Genetics of Tumours of Endocrine Organs: WHO Classification of Tumours. Vol 8. Lyon, France: IARC Press; 2004.
3. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytological diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine- Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:425-437.
4. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19: 1167-1214.
5. Faquin WC, Bongiovanni M, Sadow PM. Update in thyroid fine needle aspiration. Endocr Pathol. 2011;22:178-183.
6. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: An appraisal. Ann Intern Med. 1993;118:282-289.
7. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115:3801-3807.
8. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009;117:195-202.
9. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. New York: Springer; 2010.
10. Cibas ES, Ali SZ; NCI Thyroid FNA state of the Science Conference the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132:658-665.
11. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111:306-315.
12. Marchevsky AM, Walts AE, Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol. 2010;38:252-259.
13. Banks ND, Kowalski J, Tsai HL, et al. A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid. 2008;18:933-941.
14. Cochand-Priollet B, Dahan H, Laloi-Michelin M, et al. Immunocytochemistry with cytokeratin 19 and antihuman mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fineneedle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid. 2011;21:1067-1073.
15. Fadda G, Rossi ED, Raffaelli M, et al. Follicular thyroid neoplasms can be classified as low- And high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol. 2011;165:447-453.
16. Bartolazzi A, Orlandi F, Saggiorato E, et al. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: A prospective multicentre study. Lancet Oncol. 2008;9:543-549.
17. Sapio MR, Guerra A, Posca D, et al. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer. 2007;14:1089-1097.
18. Raggio E, Camandona M, Solerio D, et al. The diagnostic accuracy of the immunocytochemical markers in the preoperative evaluation of follicular thyroid lesions. J Endocrinol Invest. 2010;33:378-381.
19. Franco C, Martinez V, Allamand JP, et al. Molecular markers in thyroid fine-needle aspiration biopsy: A prospective study. Appl Immunohistochem Mol Morphol. 2009;17:211-215.
20. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367:705-715.
21. Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96:3390-3397.
22. Ferraz C, Eszlinger M, Paschke R. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab. 2011;96:2016-2026.
23. Tomei S, Mazzanti C, Marchetti I, et al. c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules [serial online]. J Transl Med. 2012;10:7.
24. Miettinen M, Lasota J. KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13: 205-220.
25. Natali PG, Berlingieri MT, Nicotra MR, et al. Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res. 1995;55:1787-1791.